Lenzing's Rights Window Closes as Placement and Berenberg's Doubts Take Centre Stage

Lenzing's subscription period for its capital increase ends today, with the fibre maker simultaneously scheduling an international private placement of any new shares left unclaimed by existing holders. The two events belong to the same transaction, but neither should be read as confirmation that the placement has already been wrapped up — the raise is fully underwritten, yet the mechanics of allocating and settling the stock are still in motion.

The terms on the table

The cash capital increase, first flagged a little over three weeks ago, is designed to bring in gross proceeds of roughly EUR 300 million. Lenzing has earmarked 34,756,362 new shares at a subscription price of EUR 8.65 apiece, on a 10-for-9 subscription ratio. Those conditions set the frame for both the exercise of subscription rights and the handling of the leftover stock.

Management has attached a clear purpose to the money: funding the "Grow Nonwovens, Reset Textiles" strategy and shoring up the balance sheet. That gives the financing a stated destination, though the intended use describes strategic direction rather than guaranteeing any particular earnings outcome. A fully underwritten deal says nothing about future operating results.

Settlement is a separate hurdle

The next date circled on the calendar is 23 October 2026, when settlement and delivery of the new shares — and their admission to trading — are due to begin. That step is explicitly conditional on the capital increase being entered in the commercial register. Today's placement and the planned start of trading therefore need to be viewed as distinct stages rather than a single completed event.

For shareholders, the focus now shifts from the well-known subscription terms to execution: first the placement of unsubscribed shares, then the register-dependent settlement. Only those steps carry the company beyond the announcement of the financing. Today marks an important waypoint, not the finish line for the whole process.

Berenberg's objection was never about the balance sheet

Running alongside the capital story is a separate debate about operating performance. Berenberg downgraded Lenzing from "Buy" to "Hold" a little over three weeks ago and cut its price target to EUR 17.00 from EUR 29.50. Analyst Sebastian Bray pointed to higher cotton and viscose prices failing to feed through to the company's results to the extent expected.

That argument targets a different question from capital adequacy. More financial headroom and stronger earnings are not the same thing, and investors are best served by keeping the two planes apart — the purpose of the raise on one side, the pricing pass-through Bray flagged on the other.

Market reaction has been cool

The equity market has greeted the financing with little enthusiasm. According to media reports, Lenzing shares remained under selling pressure on 8 October after the subscription period opened, with the decline tied to the previously announced capital increase. The stock closed yesterday at EUR 10.54, weaker again. That price action underscores the muted reception but, on its own, says nothing about how the private placement will fare.

What remains is a company pursuing two tracks at once: executing a guaranteed EUR 300 million raise and proving that higher raw-material prices can reach the bottom line. The financing provides one building block for assessing Lenzing — not a substitute for watching the business itself.